Correlation between Fertility Drug and the Likelihood of Gynecological Cancer - A Systematic Review.

Simi Ms
{"title":"Correlation between Fertility Drug and the Likelihood of Gynecological Cancer - A Systematic Review.","authors":"Simi Ms","doi":"10.35248/2167-0420.21.10.548","DOIUrl":null,"url":null,"abstract":"Background: There is increasing use of fertility drugs for ovulation induction and ovarian stimulation in assisted reproductive treatment like In Vitro Fertilization. For the treatment of subfertility, several medications are used to grow more eggs these drugs used to stimulate their ovaries may fuel cancer risk. In this review, recent literature regarding the correlation between fertility drug and cancer risk is reviewed to find out whether the medicines used to stimulate ovulation increase the risk of any gynecological cancer in women. Main body: Broad controversy exists in the literature about fertility treatment-induced cancer, although clinical trials are generally more focused. In order to present comprehensive strategies, the author has attempted to synthesize findings from Forty-seven research papers. The purpose of this study is to present a systematic review of the available evidence-based research paper concerning the relationship between fertility drug and gynecological cancers. Conclusion: The result of this study shows support for the correlation between fertility drugs and certain cancer risk, the correlation should continue to be monitored because the included studies had several limitations and multiple differences in the way they were conducted. However, we suggest the need to counsel women about their potential risk of Uterine/ Endometrial cancer and Breast Cancer in the future before any treatment procedure.","PeriodicalId":93471,"journal":{"name":"Journal of women's health care and management","volume":"73 1","pages":"1-9"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of women's health care and management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2167-0420.21.10.548","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: There is increasing use of fertility drugs for ovulation induction and ovarian stimulation in assisted reproductive treatment like In Vitro Fertilization. For the treatment of subfertility, several medications are used to grow more eggs these drugs used to stimulate their ovaries may fuel cancer risk. In this review, recent literature regarding the correlation between fertility drug and cancer risk is reviewed to find out whether the medicines used to stimulate ovulation increase the risk of any gynecological cancer in women. Main body: Broad controversy exists in the literature about fertility treatment-induced cancer, although clinical trials are generally more focused. In order to present comprehensive strategies, the author has attempted to synthesize findings from Forty-seven research papers. The purpose of this study is to present a systematic review of the available evidence-based research paper concerning the relationship between fertility drug and gynecological cancers. Conclusion: The result of this study shows support for the correlation between fertility drugs and certain cancer risk, the correlation should continue to be monitored because the included studies had several limitations and multiple differences in the way they were conducted. However, we suggest the need to counsel women about their potential risk of Uterine/ Endometrial cancer and Breast Cancer in the future before any treatment procedure.
生育药物与妇科癌症发生可能性的相关性——系统综述。
背景:在体外受精等辅助生殖治疗中,越来越多地使用促排卵和卵巢刺激药物。对于低生育能力的治疗,一些药物被用来培养更多的卵子,这些药物用来刺激卵巢可能会增加患癌症的风险。在这篇综述中,我们回顾了最近关于生育药物与癌症风险之间关系的文献,以找出用于刺激排卵的药物是否会增加女性患妇科癌症的风险。正文:尽管临床试验通常更集中,但关于生育治疗诱发癌症的文献中存在广泛的争议。为了提出全面的策略,作者试图综合47篇研究论文的结果。本研究的目的是对现有的以证据为基础的关于生育药物与妇科癌症关系的研究论文进行系统综述。结论:本研究结果支持生育药物与某些癌症风险之间的相关性,由于纳入的研究存在一些局限性和进行方式上的多种差异,因此应继续监测这种相关性。然而,我们建议在进行任何治疗程序之前,有必要向妇女咨询她们未来患子宫/子宫内膜癌和乳腺癌的潜在风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信